Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10888)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 24, 2021 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | O'Reilly D, Sendi MA, Kelly CM. Overview of recent advances in metastatic triple negative breast cancer. World J Clin Oncol 2021; 12(3): 164-182 [PMID: 33767972 DOI: 10.5306/wjco.v12.i3.164] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v12/i3/164.htm |
| Number | Citing Articles |
| 1 |
Onyinyechi Obidiro, Gantumur Battogtokh, Emmanuel O. Akala. Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook. Pharmaceutics 2023; 15(7): 1796 doi: 10.3390/pharmaceutics15071796
|
| 2 |
Youyang Shi, Yuanyuan Wu, Feifei Li, Kexin Jiang, Xiaofang Fang, Yu Wang, Xiaoyun Song, Rui Wang, Lixin Chen, Jinzhou Zheng, Chunyu Wu, Yuenong Qin, Xiaofei Liu, Sheng Liu. Investigating the Immunogenic Cell Death-Dependent Subtypes and Prognostic Signature of Triple-Negative Breast Cancer. Phenomics 2024; 4(1): 34 doi: 10.1007/s43657-023-00133-x
|
| 3 |
Luis Piedra-Delgado, Diego Chambergo-Michilot, Zaida Morante, Carlos Fairen, Fernando Jerves-Coello, Renato Luque-Benavides, Fresia Casas, Eduarda Bustamante, Cesar Razuri-Bustamante, J. Smith Torres-Roman, Hugo Fuentes, Henry Gomez, Alexis Narvaez-Rojas, Gabriel De la Cruz-Ku, Jhajaira Araujo, Divijendra Natha Reddy Sirigiri. Survival according to the site of metastasis in triple-negative breast cancer patients: The Peruvian experience. PLOS ONE 2024; 19(2): e0293833 doi: 10.1371/journal.pone.0293833
|
| 4 |
Harini Narasimhan, Francesca Ferraro, Andreas Bleilevens, Ralf Weiskirchen, Elmar Stickeler, Jochen Maurer. Tumor Necrosis Factor-α (TNFα) Stimulates Triple-Negative Breast Cancer Stem Cells to Promote Intratumoral Invasion and Neovasculogenesis in the Liver of a Xenograft Model. Biology 2022; 11(10): 1481 doi: 10.3390/biology11101481
|
| 5 |
Yongxiu Huang, Anqi Zeng, Linjiang Song. Facts and prospects of peptide in targeted therapy and immune regulation against triple-negative breast cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1255820
|
| 6 |
Akhilandeshwari Ravichandran, James Monkman, Ahmed M. Mehdi, Tony Blick, Cameron Snell, Arutha Kulasinghe, Laura J. Bray. The in situ transcriptomic landscape of breast tumour-associated and normal adjacent endothelial cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; 1870(2): 166985 doi: 10.1016/j.bbadis.2023.166985
|
| 7 |
Md Abdus Subhan, Farzana Parveen, Hassan Shah, Satya Siva Kishan Yalamarty, Janaína Artem Ataide, Valdimir P. Torchilin. Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type. Cancers 2023; 15(8): 2204 doi: 10.3390/cancers15082204
|
| 8 |
Ji Hyeon Kim, Jung Min Park, Eunsun Jung, Jieun Lee, Jiyou Han, Yoon-Jae Kim, Ji Young Kim, Jae Hong Seo, Jong Seung Kim. A synchronized dual drug delivery molecule targeting cancer stem cells in tumor heterogeneity and metastasis. Biomaterials 2022; 289: 121781 doi: 10.1016/j.biomaterials.2022.121781
|
| 9 |
Sibylle Loibl, Delphine Loirat, Sara M. Tolaney, Kevin Punie, Mafalda Oliveira, Hope S. Rugo, Aditya Bardia, Sara A. Hurvitz, Adam M. Brufsky, Kevin Kalinsky, Javier Cortés, Joyce A. O'Shaughnessy, Véronique Dieras, Lisa A. Carey, Luca Gianni, Mahdi Gharaibeh, Luciana Preger, See Phan, Lawrence Chang, Ling Shi, Martine J. Piccart. Health-related quality of life in the phase III ASCENT trial of sacituzumab govitecan versus standard chemotherapy in metastatic triple-negative breast cancer. European Journal of Cancer 2023; 178: 23 doi: 10.1016/j.ejca.2022.10.003
|
| 10 |
Marine C. N. M. Blackman, Tania Capeloa, Justin D. Rondeau, Luca X. Zampieri, Zohra Benyahia, Justine A. Van de Velde, Maude Fransolet, Evangelos P. Daskalopoulos, Carine Michiels, Christophe Beauloye, Pierre Sonveaux. Mitochondrial Protein Cox7b Is a Metabolic Sensor Driving Brain-Specific Metastasis of Human Breast Cancer Cells. Cancers 2022; 14(18): 4371 doi: 10.3390/cancers14184371
|
| 11 |
Alejandra Estepa-Fernández, Alba García-Fernández, Araceli Lérida-Viso, Juan F. Blandez, Irene Galiana, Félix Sancenon-Galarza, Mar Orzáez, Ramón Martínez-Máñez. Combination of palbociclib with navitoclax based-therapies enhances in vivo antitumoral activity in triple-negative breast cancer. Pharmacological Research 2023; 187: 106628 doi: 10.1016/j.phrs.2022.106628
|
| 12 |
Wenlu Yan, Yu Li, Yiting Zou, Runqi Zhu, Ting Wu, Xujie Sun, Wenhui Yuan, Tianqun Lang, Qi Yin, Yaping Li. Breaking Tumor Immunosuppressive Network by Regulating Multiple Nodes with Triadic Drug Delivery Nanoparticles. ACS Nano 2023; 17(18): 17826 doi: 10.1021/acsnano.3c03387
|
| 13 |
Yun-Chi Wang, Jie-Long He, Chung-Lin Tsai, Huey-En Tzeng, Wen-Shin Chang, Shih-Han Pan, Li-Hsiou Chen, Chen-Hsien Su, Jiunn-Cherng Lin, Chih-Chiang Hung, Da-Tian Bau, Chia-Wen Tsai. The Contribution of Tissue Inhibitor of Metalloproteinase-2 Genotypes to Breast Cancer Risk in Taiwan. Life 2023; 14(1): 9 doi: 10.3390/life14010009
|
| 14 |
Versha Pleasant. A Public Health Emergency. Obstetrics and Gynecology Clinics of North America 2024; 51(1): 69 doi: 10.1016/j.ogc.2023.11.001
|
| 15 |
Anna Wawruszak, Marta Halasa, Estera Okon, Wirginia Kukula-Koch, Andrzej Stepulak. Valproic Acid and Breast Cancer: State of the Art in 2021. Cancers 2021; 13(14): 3409 doi: 10.3390/cancers13143409
|
| 16 |
Shom Goel, Antoinette R Tan, Hope S Rugo, Philippe Aftimos, Zoran Andrić, Andrew Beelen, Jingshan Zhang, John S Yi, Rajesh Malik, Joyce O'Shaughnessy. Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2. Future Oncology 2022; 18(33): 3701 doi: 10.2217/fon-2022-0773
|
| 17 |
Thodoris Sklias, Vasileios Vardas, Evangelia Pantazaka, Athina Christopoulou, Vassilis Georgoulias, Athanasios Kotsakis, Yiannis Vasilopoulos, Galatea Kallergi. PARP-1 Expression and BRCA1 Mutations in Breast Cancer Patients’ CTCs. Cancers 2022; 14(7): 1731 doi: 10.3390/cancers14071731
|
| 18 |
Manosi Banerjee, V. Devi Rajeswari. A novel cross-communication of HIF-1α and HIF-2α with Wnt signaling in TNBC and influence of hypoxic microenvironment in the formation of an organ-on-chip model of breast cancer. Medical Oncology 2023; 40(8) doi: 10.1007/s12032-023-02112-8
|
| 19 |
Nevin Erk, Özgül Vural, Wiem Bouali, Asena Ayse Genc, Lalitha Gnanasekaran, Hassan Karimi-Maleh. Smart and sensitive nanomaterial-based electrochemical sensor for the determination of a poly (ADP-ribose) polymerase (PARP) inhibitor anticancer agent. Environmental Research 2023; 238: 117082 doi: 10.1016/j.envres.2023.117082
|
| 20 |
Binghe Xu, Fei Ma, Tao Wang, Shusen Wang, Zhongsheng Tong, Wei Li, Xinhong Wu, Xiaojia Wang, Tao Sun, Yueyin Pan, Herui Yao, Xian Wang, Ting Luo, Jin Yang, Xiaohua Zeng, Weihong Zhao, Xiuyu Julie Cong, Jiongjie Chen. A Phase IIb, single arm, multicenter trial of sacituzumab govitecan in Chinese patients with metastatic triple‐negative breast cancer who received at least two prior treatments. International Journal of Cancer 2023; 152(10): 2134 doi: 10.1002/ijc.34424
|
| 21 |
Shih-Hsuan Chan, Wen-Hung Kuo, Lu-Hai Wang. SCEL regulates switches between pro-survival and apoptosis of the TNF-α/TNFR1/NF-κB/c-FLIP axis to control lung colonization of triple negative breast cancer. Journal of Biomedical Science 2023; 30(1) doi: 10.1186/s12929-023-00986-4
|
| 22 |
Hua Yang, Yongjun Liu. RETRACTED: Kinesin Family Member 2A Serves as a Potential Biomarker Reflecting More Frequent Lymph Node Metastasis and Tumor Recurrence Risk in Basal-Like Breast Cancer Patients. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.889294
|
| 23 |
Ayesha Khan, Md Abu Sayed, Khaled Hosny, Godwins Echejoh, Santhi Kumar. Incidentaloma on Staging CT Revealed to Be Breast to Renal Tumour-to-Tumour Metastasis. Cureus 2023; doi: 10.7759/cureus.45658
|
| 24 |
Maria Rosaria Valerio, Pietro Spadaro, Concetta Arcanà, Nicolò Borsellino, Calogero Cipolla, Paolo Vigneri, Dario Piazza, Vittorio Gebbia. Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis. Future Science OA 2021; 7(10) doi: 10.2144/fsoa-2020-0095
|
| 25 |
Soyoung Kim, Ilseob Choi, Ik-Hwan Han, Hyunsu Bae. Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer. International Journal of Molecular Sciences 2022; 23(24): 15751 doi: 10.3390/ijms232415751
|
| 26 |
Jaspreet Kaur, Darshan S. Chandrashekar, Zsuzsanna Varga, Bettina Sobottka, Emiel Janssen, Khanjan Gandhi, Jeanne Kowalski, Umay Kiraz, Sooryanarayana Varambally, Ritu Aneja. Whole-Exome Sequencing Reveals High Mutational Concordance between Primary and Matched Recurrent Triple-Negative Breast Cancers. Genes 2023; 14(9): 1690 doi: 10.3390/genes14091690
|
| 27 |
Débora Ferreira, Cátia Santos-Pereira, Marta Costa, Julieta Afonso, Sujuan Yang, Janine Hensel, Kathleen M. McAndrews, Adhemar Longatto-Filho, Rui Fernandes, Joana B. Melo, Fátima Baltazar, João N. Moreira, Raghu Kalluri, Ligia R. Rodrigues. Exosomes modified with anti-MEK1 siRNA lead to an effective silencing of triple negative breast cancer cells. Biomaterials Advances 2023; 154: 213643 doi: 10.1016/j.bioadv.2023.213643
|
| 28 |
Luyao Dai, Hanxiao Cui, Yuanhang Bao, Liqun Hu, Zhangjian Zhou, Meng Wang, Shuai Lin, Hao Wu, Huafeng Kang, Xiaobin Ma. The relationship between immediate postmastectomy reconstruction modalities and survival benefits in patients with triple negative breast cancer. Cancer Medicine 2023; 12(3): 2782 doi: 10.1002/cam4.5166
|
| 29 |
Fu-Ying Qin, Yan-Yi Chen, Jiao-Jiao Zhang, Yong-Xian Cheng. Meroterpenoid Dimers from Ganoderma Mushrooms and Their Biological Activities Against Triple Negative Breast Cancer Cells. Frontiers in Chemistry 2022; 10 doi: 10.3389/fchem.2022.888371
|
| 30 |
Alejandra Estepa-Fernández, Alba García-Fernández, Araceli Lérida-Viso, Ángela Morellá-Aucejo, Juan José Esteve-Moreno, Juan F. Blandez, María Alfonso, Vicente Candela-Noguera, Gema Vivo-Llorca, Félix Sancenon-Galarza, Mar Orzáez, Ramón Martínez-Máñez. Engineering nanoparticle communication in living systems by stigmergy: An application to enhance antitumor therapy in triple-negative breast cancer. Nano Today 2023; 48: 101692 doi: 10.1016/j.nantod.2022.101692
|
| 31 |
Liyang Yin, Renxian Cao, Zhuoqing Liu, Gang Luo, Yu Li, Xiaolong Zhou, Xiguang Chen, Ying Wu, Jun He, Xuyu Zu, Yingying Shen. FUNDC2, a mitochondrial outer membrane protein, mediates triple-negative breast cancer progression via the AKT/GSK3β/GLI1 pathway. Acta Biochimica et Biophysica Sinica 2023; doi: 10.3724/abbs.2023142
|
| 32 |
Pan Wang, Wenju Chen, Yaqiong Zhang, Qianyi Zhong, Zhaoyun Li, Yichao Wang. MicroRNA-1246 suppresses the metastasis of breast cancer cells by targeting the DYRK1A/PGRN axis to prevent the epithelial-mesenchymal transition. Molecular Biology Reports 2022; 49(4): 2711 doi: 10.1007/s11033-021-07080-8
|
| 33 |
Daire Hanna, Sophie Merrick, Aruni Ghose, Michael John Devlin, Dorothy D. Yang, Edward Phillips, Alicia Okines, Neha Chopra, Elisavet Papadimatraki, Kirsty Ross, Iain Macpherson, Zhuang Y. Boh, Caroline O. Michie, Angela Swampillai, Sunnia Gupta, Tim Robinson, Lewis Germain, Chris Twelves, Charlotte Atkinson, Apostolos Konstantis, Pippa Riddle, Nicola Cresti, Jay D. Naik, Annabel Borley, Amy Guppy, Peter Schmid, Melissa Phillips. Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom. British Journal of Cancer 2024; doi: 10.1038/s41416-024-02685-9
|
| 34 |
Kitty Y. Wu, Kirsten M. Hayford, Robert J. Spinner. In search of zebras: Critical analysis of the rarity of perineural breast cancer spread to the brachial plexus in men. Journal of Plastic, Reconstructive & Aesthetic Surgery 2024; 88: 231 doi: 10.1016/j.bjps.2023.10.139
|
| 35 |
Zhi Li, Chloe Nguyen, Hongje Jang, David Hoang, SoeSu Min, Ellen Ackerstaff, Jason A. Koutcher, Lingyan Shi. Multimodal imaging of metabolic activities for distinguishing subtypes of breast cancer. Biomedical Optics Express 2023; 14(11): 5764 doi: 10.1364/BOE.500252
|
| 36 |
Lisa Hong, Dennis C. Braden, Yaoning Zhao, John J. Skoko, Fei Chang, Steven R. Woodcock, Crystall Uvalle, Allison Casey, Katherine Wood, Sonia R. Salvatore, Alparslan Asan, Trey Harkness, Adeola Fagunloye, Mortezaali Razzaghi, Adam Straub, Maria Spies, Daniel D. Brown, Adrian V. Lee, Francisco Schopfer, Bruce A. Freeman, Carola A. Neumann. Small molecule nitroalkenes inhibit RAD51-mediated homologous recombination and amplify triple-negative breast cancer cell killing by DNA-directed therapies. Redox Biology 2023; 66: 102856 doi: 10.1016/j.redox.2023.102856
|
| 37 |
Manosi Banerjee, Vijayarangan Devi Rajeswari. Critical Review on the Different Roles of Exosomes in TNBC and Exosomal-Mediated Delivery of microRNA/siRNA/lncRNA and Drug Targeting Signalling Pathways in Triple-Negative Breast Cancer. Molecules 2023; 28(4): 1802 doi: 10.3390/molecules28041802
|
| 38 |
Ali Mussa, Hafeez Abiola Afolabi, Nazmul Huda Syed, Mustafa Talib, Ahmad Hafiz Murtadha, Khalid Hajissa, Noor Fatmawati Mokhtar, Rohimah Mohamud, Rosline Hassan. The NF-κB Transcriptional Network Is a High-Dose Vitamin C-Targetable Vulnerability in Breast Cancer. Biomedicines 2023; 11(4): 1060 doi: 10.3390/biomedicines11041060
|
| 39 |
Tomohiro Tanaka, Tomokazu Ohishi, Masaki Saito, Manabu Kawada, Mika K. Kaneko, Yukinari Kato. TrMab-6 Exerts Antitumor Activity in Mouse Xenograft Models of Breast Cancers. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 2022; 41(1): 32 doi: 10.1089/mab.2021.0056
|
| 40 |
Aditya Bardia, Ian E. Krop, Takahiro Kogawa, Dejan Juric, Anthony W. Tolcher, Erika P. Hamilton, Toru Mukohara, Aaron Lisberg, Toshio Shimizu, Alexander I. Spira, Junji Tsurutani, Senthil Damodaran, Kyriakos P. Papadopoulos, Jonathan Greenberg, Fumiaki Kobayashi, Hong Zebger-Gong, Rie Wong, Yui Kawasaki, Tadakatsu Nakamura, Funda Meric-Bernstam. Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study. Journal of Clinical Oncology 2024; doi: 10.1200/JCO.23.01909
|
| 41 |
Juvin Ann Thomas, Athira Gireesh Gireesh Moly, Hima Xavier, Priya Suboj, Amit Ladha, Gaurav Gupta, Santosh Kumar Singh, Partha Palit, Suboj Babykutty. Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point?. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1063051
|